One of the biggest bills of the year is one nobody is talking about, Del. Mike Mullin, D-Newport News, wrote in a tweet on Friday — a hard cap on the price of insulin in Virginia.
Insurers are now limited to charging a maximum of $50 a month for the drug after Del. Lee Carter, D-Manassas, urged colleagues to accept a Senate amendment to his bill. The price is a little higher than his original cap of $30, but still the lowest ceiling for insulin in the country, he said on the House floor.
There have been Congressional hearings over the rising costs, but federal regulators still haven’t settled on a solution to lower prices. Virginia is the third state to pass a law limiting the cost of insulin.
The bill will go to Gov. Ralph Northam for final approval.
“This is aimed at providing relief for folks who have health insurance but still can’t afford their medication,” Carter said during a Senate committee hearing on the bill. “And with Medicaid expansion, that’s going to cover a vast swath of Virginia’s population.”
The legislation prohibits Virginia insurers from setting a patient’s cost-sharing payment for insulin above $50 a month — including deductibles and copays. The bill was supported by the Medical Society of Virginia and the American Association of Retired Persons, but, unsurprisingly, not by the Virginia Association of Health Plans, which argued that the cap on cost-sharing payments would be offset by a rise in premiums.
The Virginia Mercury is a nonpartisan, nonprofit news organization covering Virginia government and policy.